<?xml version='1.0' encoding='UTF-8'?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/" xmlns:blogger="http://schemas.google.com/blogger/2008" xmlns:georss="http://www.georss.org/georss" xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr="http://purl.org/syndication/thread/1.0" version="2.0"><channel><atom:id>tag:blogger.com,1999:blog-868356934935513032</atom:id><lastBuildDate>Thu, 24 Oct 2024 14:33:37 +0000</lastBuildDate><category>Pharma Marketing Blog</category><category>Dr. Peter Rost</category><category>Pharmalot</category><category>BrandweekNRX</category><category>&#39;Round the Sphere</category><category>PharmaGossip</category><category>Survey</category><category>Pfizer</category><category>Drug Wonks</category><category>SiCKO</category><category>Ed Silverman</category><category>Cafe Pharma</category><category>Johnson and Johnson</category><category>Michael Moore</category><category>Pharma Giles</category><category>Blog Review</category><category>Journalists</category><category>Chris Truelove</category><category>podcast</category><category>World of DTC Marketing</category><category>impactiviti</category><category>HealthcareVox</category><category>WSJ Health Blog</category><category>CNTO411</category><category>Ethics</category><category>GSK</category><category>PhRMA Intern</category><category>Pharma Marketing News</category><category>Weird Stuff</category><category>censorship</category><category>eDrugSearch</category><category>AstraZeneca</category><category>Bob Ehrlich</category><category>CL Psych Blog</category><category>Centocor</category><category>DTC</category><category>Eye On FDA</category><category>FDA</category><category>Fard Johnmar</category><category>Gardasil</category><category>Jim Edwards</category><category>John Mack</category><category>Montel Williams</category><category>Outer Sphere</category><category>Pharma Marketing Talk</category><category>Sex</category><category>The Black Kitty</category><category>In the Pipeline</category><category>Industry Critics</category><category>Jack Friday</category><category>Merck</category><category>NRx</category><category>On Pharma</category><category>Peter Pitts</category><category>PhRMA</category><category>Pharmalyst</category><category>Rozerem</category><category>Takeda</category><category>Whistleblowers</category><category>AZ Group of Seven</category><category>Avandia</category><category>Controversy</category><category>FDA Commissioner</category><category>Gifts to Physicians</category><category>Healthcare Blogging Summit</category><category>JNJ BTW</category><category>Jarvik</category><category>Mack</category><category>Marc Monseau</category><category>McCain</category><category>Obama</category><category>PR Wonks</category><category>Pharm Aid</category><category>Politics</category><category>RLS</category><category>Recession</category><category>Spoof</category><category>Web 2.0</category><category>Whistle Blowers</category><category>alli</category><category>pharmagather</category><category>Agnes Shanley</category><category>Awards</category><category>Code of Conduct</category><category>Cupcakes</category><category>Drug Channels</category><category>Drug Safety</category><category>Drug Wankers</category><category>DrugWanks</category><category>Health Care Renewal</category><category>Heirarchy of Spheres</category><category>IgniteBlog</category><category>Joke</category><category>Legal</category><category>Lilly</category><category>Lipitor</category><category>MMM</category><category>Michael Parks</category><category>Mission</category><category>Party</category><category>Pfizer Rep Bill of Rights</category><category>Pharma Blogs</category><category>Pharma Ethics My Foot</category><category>Pharma Gazette</category><category>Pharma Rag</category><category>Pharma Rep Clinic</category><category>Pharma Watch</category><category>PharmaFraud</category><category>Red Cross</category><category>Rx Daily Dose</category><category>Schering-Plough</category><category>Steve Woodruff</category><category>Susan Wood</category><category>THCB</category><category>Tricks</category><category>Viagra</category><category>Vytorin</category><category>Zimulti</category><category>swedish spinmeister</category><category>Acomplia</category><category>AdAge</category><category>Advergaming</category><category>Advertising policy</category><category>Beaver Contest</category><category>BigPharmaRealPeople</category><category>Blogger radar</category><category>Blogging Rules</category><category>Boston Globe</category><category>Botox</category><category>Bush</category><category>CDC</category><category>Carlat Psychiatry Blog</category><category>Cary Byrd</category><category>Catalyst Online Blog</category><category>Cause Marketing</category><category>CentocorGossip</category><category>Chantix</category><category>Classifucation</category><category>Confarta</category><category>Corporate Blogging</category><category>Cymbalta</category><category>DTC Blogspectives</category><category>Daily Diagnosis</category><category>Dormant Asteriod</category><category>Dream Blog Panel</category><category>Drug Injury Watch</category><category>ENHANCE</category><category>Employee Blog</category><category>Exubera</category><category>Fabio Gratton</category><category>Fred Hassan</category><category>Free Lunch</category><category>Free Speech</category><category>Fun Stuff</category><category>GSK alli Bollox</category><category>Garnier</category><category>Getting Personal</category><category>Girl Scouts</category><category>Girl from Google</category><category>Giuliani</category><category>Glaxo</category><category>Goodbye</category><category>Google Blog Search</category><category>HHS</category><category>Halloween Costumes</category><category>Health Populi</category><category>HealthDot</category><category>Henessey</category><category>Hooked</category><category>Hooked on Ethics</category><category>Industry Defenders</category><category>Inner Planets</category><category>JAMA</category><category>James Chasse</category><category>Jane Sarasohn-Kahn</category><category>Jarvick</category><category>Jay Bernhardt</category><category>Jekyll and Hyde</category><category>Jim Edwards’ NRx</category><category>Kaiser Permanante</category><category>LRRH</category><category>Labs&#39; Insder</category><category>Lobbying</category><category>London 2008</category><category>Lyrica</category><category>Marilyn vos Savant</category><category>Marketing</category><category>Marketing Overdose Blog</category><category>Medical Weblog</category><category>Melissa Katz</category><category>Moment of Silence</category><category>Motivational Deficiency Disorder</category><category>Networking Reception</category><category>Novartis</category><category>OnThePharm</category><category>Open Healthcare</category><category>Orange Book Blog</category><category>PAL Blog</category><category>PDUFA</category><category>Panama Hats</category><category>Partners for Prescription Assitance</category><category>Patient Centric Healthcare Blog</category><category>Pharma 2.0</category><category>Pharma Blog Review</category><category>Pharma Blogs Week in Review</category><category>Pharma Co-optation</category><category>Pharma Law Blog</category><category>Pharma eMarketing Pioneers</category><category>PharmaCenbtral</category><category>PharmaCentral</category><category>Pharmablogger</category><category>Pharmaceutical Executive Magazine</category><category>Pharmalittle</category><category>Pharmanalyst</category><category>Poetry</category><category>Political Compass</category><category>Postscript</category><category>Prozac</category><category>Question Authority</category><category>Readability</category><category>Republican think tanks</category><category>Requip</category><category>Rich Meyer</category><category>Rupert Murdoch</category><category>Sanofi-Aventis</category><category>Sarah Palmer</category><category>Scientific Misconduct Blog</category><category>Scios</category><category>Scott Hensley</category><category>Screening</category><category>Seal of Approval</category><category>Sepracor</category><category>Sermo</category><category>Social Media Summit</category><category>Statistics</category><category>Steven Nissen</category><category>T-shirt</category><category>TOP 100 healthcare Blogs</category><category>Taurel</category><category>Thanksgiving</category><category>The Group Guy</category><category>The Science Business</category><category>Trusted.MD</category><category>Twiiter</category><category>Twitter</category><category>Villanova</category><category>Virapen</category><category>Whats Next</category><category>Wikepedia</category><category>Winchell</category><category>Women in ads</category><category>YouTube</category><category>Zetia</category><category>alliconnect</category><category>eCTD</category><category>newly discovered</category><category>qui tam</category><category>social media</category><title>Pharma BlogoSphereTM</title><description>A Blog about Blogging about the Pharmaceutical Industry!</description><link>http://pharmablogosphere.blogspot.com/</link><managingEditor>noreply@blogger.com (PharmaGuy)</managingEditor><generator>Blogger</generator><openSearch:totalResults>293</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-3993527786264568804</guid><pubDate>Wed, 20 May 2009 14:00:00 +0000</pubDate><atom:updated>2009-05-20T09:13:15.515-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Goodbye</category><category domain="http://www.blogger.com/atom/ns#">Twiiter</category><title>I&#39;m Out of Here! Twitter is Better. Follow Me There.</title><atom:summary type="text">Some of you may have noticed recently that we’ve been on well… a bit of a break… and I thought it high time to let you know what’s up with CNTO411, I mean Pharma BlogoSphere.The long and the short of it is that I don&#39;t have the time to write long posts to this blog about other pharma-related blogs and bloggers.I&#39;ve decided that Twitter is Better!It only requires 140 characters! It helps me </atom:summary><link>http://pharmablogosphere.blogspot.com/2009/05/im-out-of-here-twitter-is-better-follow.html</link><author>noreply@blogger.com (PharmaGuy)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-4703702949069549368</guid><pubDate>Wed, 01 Apr 2009 11:31:00 +0000</pubDate><atom:updated>2009-04-01T07:12:03.123-05:00</atom:updated><title>Dozens of Pharma Blogosphere Bloggers Call It Quits: Cite Economy</title><atom:summary type="text">&quot;Following Pharmalot&#39;s closure and Scott Hensley&#39;s departure from the WSJ Health Blog, Insider has decided to throw in the towel.&quot; -- Jack Friday at PharmaGossip&quot;I have to focus on making a living and writing a blog just isn&#39;t enough,&quot; said Steve Woodruff after he shut down his Impactiviti blog.The list goes on.Only two bloggers remain:John Mack - Pharma Marketing BlogPeter Pitts - Drug Wonks </atom:summary><link>http://pharmablogosphere.blogspot.com/2009/04/dozens-of-pharma-blogosphere-bloggers.html</link><author>noreply@blogger.com (PharmaGuy)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-154155219982547666</guid><pubDate>Mon, 23 Mar 2009 13:33:00 +0000</pubDate><atom:updated>2009-03-23T08:44:23.331-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Scott Hensley</category><category domain="http://www.blogger.com/atom/ns#">WSJ Health Blog</category><title>Scott Hensley Quits! What&#39;s in Store for WSJ Health Blog?</title><atom:summary type="text">I noticed that lately the Wall Street Journal Health Blog was a bit light on number of posts being made. At first I thought that not having Ed Silverman and Pharmalot to compete against, the folks at WSJ Health Blog were just being lazy. But now I learn that Scott Hensley is leaving. Here&#39;s his farewell post:A little more than two years ago, I first clicked the publish button on this blog, </atom:summary><link>http://pharmablogosphere.blogspot.com/2009/03/scott-hensley-quits-whats-in-store-for.html</link><author>noreply@blogger.com (PharmaGuy)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-2716388962820596292</guid><pubDate>Wed, 18 Mar 2009 14:48:00 +0000</pubDate><atom:updated>2009-03-18T09:57:49.131-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">CNTO411</category><title>Pharma Blogosphere Update</title><atom:summary type="text">Several blogs in the Pharma Blogosphere are now going dark (see &quot;CNTO411: We&#39;ll Meet Again, Don&#39;t Know Where, Don&#39;t Know When&quot;), which is why I am writing this post.Around this time a few months ago, John Mack introduced the blog Pharma Blogosphere to offer perspective about blogging about the pharmaceutical industry. Though we were initially pretty good at posting content, some of you may have </atom:summary><link>http://pharmablogosphere.blogspot.com/2009/03/pharma-blogosphere-update.html</link><author>noreply@blogger.com (PharmaGuy)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-3382515449791410387</guid><pubDate>Fri, 16 Jan 2009 15:36:00 +0000</pubDate><atom:updated>2009-01-16T10:41:39.405-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Pharmalittle</category><category domain="http://www.blogger.com/atom/ns#">Pharmalot</category><title>Pharmalot Refugees Launch Pharmalittle Blog</title><atom:summary type="text">This note comes in from pharmalot refugees &#39;Justice in Michigan&#39; and &#39;Jaynesday&#39;In fondest tribute to Ed Silverman and his extraordinary Pharmalot site, and with appreciation to the Newark Star Ledger for sponsoring Pharmalot, a few of us Pharmalot &quot;refugees&quot; have founded the site, &quot;Pharmalittle&quot;.This is an all-volunteer, unfunded effort.  Needless to say, it ain&#39;t no Pharmalot.  Our hope is </atom:summary><link>http://pharmablogosphere.blogspot.com/2009/01/pharmalot-refugees-launch-pharmalittle.html</link><author>noreply@blogger.com (PharmaGuy)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjISdbhUlFQTNJHo4yx0dukuMZjI_gu8ePaqwrFg9cGD38muEynGeozfMDJUlI87lw9xDJ_OgxLl8ERUJYBg67XwzGFhSfx_4uZR2hYPrh9uPCeZXmTeshYjt8eBsO5hrrV_K_rU7MyANQ/s72-c/bigscoop-orange.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-2972340588010015438</guid><pubDate>Wed, 14 Jan 2009 12:36:00 +0000</pubDate><atom:updated>2009-01-14T07:56:36.777-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Dr. Peter Rost</category><title>Peter von Rost?</title><atom:summary type="text">Every aspiring king, prince, or FDA Commissioner should have a family &quot;shield&quot; (aka &quot;coat of arms&quot;) to use on his letterhead and Peter Rost, who aspires to be the new FDA commish, says someone sent him just the shield he&#39;s been &quot;looking for&quot; (that&#39;s it on the left; see the original here).BTW, back in January, 2008, when I was writing about Rost speaking before the Swedish parliament, I came up </atom:summary><link>http://pharmablogosphere.blogspot.com/2009/01/peter-von-rost.html</link><author>noreply@blogger.com (PharmaGuy)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgpicQk_QbWiEreMx9u_jcgdoLpFj6HwxejW-GCTP4LArq_qW84nKbXjlqcBp9IpPGRQuJIekmbmMybgzq56IqAMmq44HvYnnhXaRwumoSYt1PlejXU8HBdtVXRUyrAmlEznp75PmmsKZ8/s72-c/vonRost2.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-1256782205213543682</guid><pubDate>Tue, 06 Jan 2009 13:14:00 +0000</pubDate><atom:updated>2009-01-06T08:21:30.415-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Ed Silverman</category><category domain="http://www.blogger.com/atom/ns#">Pharmalot</category><title>Pharmalot Folds: Good Bye and Good Luck to Ed Silverman</title><atom:summary type="text">I was sorry to hear that Ed Silverman &quot;took the money and ran&quot; and will no longer be writing for Pharmalot, which I assume will fold without him. I will miss Ed&#39;s presence in the Pharma Blogosphere, although I am sure he will continue to contribute somehow.&quot;This is my long goodbye,&quot; said Ed in his final post.&quot;For two glorious years, I have had the privilege and good fortune to run this site. Now,</atom:summary><link>http://pharmablogosphere.blogspot.com/2009/01/pharmalot-folds-good-bye-and-good-luck.html</link><author>noreply@blogger.com (PharmaGuy)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-8234699768344661209</guid><pubDate>Thu, 04 Dec 2008 15:24:00 +0000</pubDate><atom:updated>2008-12-04T10:51:46.534-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Dr. Peter Rost</category><category domain="http://www.blogger.com/atom/ns#">FDA Commissioner</category><category domain="http://www.blogger.com/atom/ns#">Susan Wood</category><title>Rost for FDA Commish Gains Support from Senator, Congresswoman, and Blogger</title><atom:summary type="text">As I reported on Pharma Marketing Blog, Peter Rost -- who has made a reputation as whistle blower, muckraker, and Pfizer nemesis -- holds the lead in my &quot;Who Should Obama Nominate for FDA Commissioner?&quot; survey (see &quot;Meet the Person Likely to be the Next FDA Commissioner&quot;).Today, I received a note from Rost that reproduced email he received from U.S. Senator Sherrod Brown and U.S. Representative </atom:summary><link>http://pharmablogosphere.blogspot.com/2008/12/rost-for-fda-commish-gains-support-from.html</link><author>noreply@blogger.com (PharmaGuy)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgUYbl4JgljTjI1ptWskN0y_XNYv9rtsC7AaP_v_2UwDIt4l-B1lgBN14Z4Sq2Emb9skutdS3_ilx5eo_ZNNCDTFavbVlz7U3MR5IBXJinlbUnefU3ZBPedh3it_xTMalnyUL2UXoX8uFg/s72-c/SenatorBrownSupportsRost.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-5516215377883695761</guid><pubDate>Thu, 20 Nov 2008 21:30:00 +0000</pubDate><atom:updated>2008-11-21T08:47:46.731-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Ed Silverman</category><title>Is Ed Silverman Interviewing for a New Job?</title><atom:summary type="text">Yesterday, Ed Silverman -- the prolific Pharmalot blogger -- wrote that he was taking the afternoon off for a &quot;speaking&quot; engagement at a major pharmaceutical company:&quot;Pardon the interruption this afternoon,&quot; Ed wrote, &quot;but believe it or not, we have again been asked to talk about what we do - you know, covering pharma and this new media world in which we live. Who asked us this time? Well, if you</atom:summary><link>http://pharmablogosphere.blogspot.com/2008/11/is-ed-silverman-interviewing-for-new.html</link><author>noreply@blogger.com (PharmaGuy)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-4983835641289494352</guid><pubDate>Sun, 16 Nov 2008 14:54:00 +0000</pubDate><atom:updated>2008-11-16T10:33:31.224-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Dr. Peter Rost</category><category domain="http://www.blogger.com/atom/ns#">FDA</category><category domain="http://www.blogger.com/atom/ns#">FDA Commissioner</category><category domain="http://www.blogger.com/atom/ns#">Steven Nissen</category><category domain="http://www.blogger.com/atom/ns#">Susan Wood</category><title>Peter Rost&#39;s Blog&#39;s New Name: Peter Rost for FDA Commissioner</title><atom:summary type="text">Today I noticed that Peter Rost -- former Pfizer Marketing VP, turned drug industry whistle blower, author, and blogger -- changed the name of his blog (again!) to PETER ROST FOR FDA COMMISSIONER.It all started when I reported on Pharma marketing Blog that FDA Intern -- Strange visitor from an Ivy League school who came to FDA with powers and ability far beyond those of Janet Woodcock or even FDA</atom:summary><link>http://pharmablogosphere.blogspot.com/2008/11/peter-rosts-blogs-new-name-peter-rost.html</link><author>noreply@blogger.com (PharmaGuy)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-4658883803925792126</guid><pubDate>Wed, 12 Nov 2008 22:08:00 +0000</pubDate><atom:updated>2008-11-12T17:16:39.764-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">alli</category><category domain="http://www.blogger.com/atom/ns#">alliconnect</category><title>Has the alliconnect Blog Been Abandoned?</title><atom:summary type="text">The last post made to the alliconnect blog was on September 3, 2008 (see screen shot below).</atom:summary><link>http://pharmablogosphere.blogspot.com/2008/11/has-alliconnect-blog-been-abandoned.html</link><author>noreply@blogger.com (PharmaGuy)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEirIAXkgunqkyZPCLhKQk9Ziu1AWhyphenhyphen5Cy3khqgCQlkMsh6jzHAbX-aeIwwaOpzV3qsEXyww6wYWkxdKBYmJqXjqZ8xbF30BbG7byLqlRVUhZluNcOA5GEaDA5ZR_6Im-Vqg_hTFXsPkaZA/s72-c/alli-old.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-4058842438615506539</guid><pubDate>Wed, 12 Nov 2008 14:57:00 +0000</pubDate><atom:updated>2008-11-12T09:59:53.561-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">FDA</category><category domain="http://www.blogger.com/atom/ns#">FDA Commissioner</category><title>Who Do You Think Should be the New FDA Commissioner?</title><atom:summary type="text">Click on the image to take the survey</atom:summary><link>http://pharmablogosphere.blogspot.com/2008/11/who-do-you-think-should-be-new-fda.html</link><author>noreply@blogger.com (PharmaGuy)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhUOWaw4INvxkNBKrMXsPKSyeuIzSTm0dSaP6SP9l7LLUxC3lNBhBKBoKZLvKmhWWYD7-uouPqWVleKtjHzX0CRZdSbmYW7kYrxI7gs6Ehk3xYI8tlqreW4W9qxExllRqDyZv1dAAP5Igo/s72-c/FDASurveyAd_350x550.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-6456171063790050020</guid><pubDate>Thu, 06 Nov 2008 18:58:00 +0000</pubDate><atom:updated>2008-11-06T14:09:59.850-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Pharma 2.0</category><title>Pharma 2.0: A New (to me) Blog in the Pharma Blogosphere</title><atom:summary type="text">I just discovered or re-discovered Pharma 2.0, which is a blog written by Bunny (aka Beatrice) Ellerin who is a Managing Director in the New York office of InterbrandHealth, a brand consultancy, which is part of Interbrand, which is part of the marketing communications giant Omnicom.Bunny leads the research division and is responsible for all facets of the business including operational </atom:summary><link>http://pharmablogosphere.blogspot.com/2008/11/pharma-20-new-to-me-blog-in-pharma.html</link><author>noreply@blogger.com (PharmaGuy)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-8563207557494565249</guid><pubDate>Mon, 27 Oct 2008 16:03:00 +0000</pubDate><atom:updated>2008-10-27T11:36:34.446-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Ed Silverman</category><category domain="http://www.blogger.com/atom/ns#">Pharmalot</category><title>Let&#39;s Hope Pharmalot Survives!</title><atom:summary type="text">This past week I noticed 3 indicators that Ed Silverman, author of Pharmalot, may soon be losing his job at the New Jersey Star-Ledger, the newspaper that owns Pharmalot.First, Insider over at PharmaGossip picked up the story of trouble at the Star-Ledger (see &quot;Let&#39;s Hope Ed at Pharmalot is OK&quot;):The Star-Ledger of Newark, N.J., will reduce its newsroom staff by nearly half through voluntary </atom:summary><link>http://pharmablogosphere.blogspot.com/2008/10/lets-hope-pharmalot-survives.html</link><author>noreply@blogger.com (PharmaGuy)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgalHGQ2xqG7TYql89fL5hPK4tAfDSkXIaO9uQg4GFIIqjkBU2XO4ryMjaoJI7dC0Q19Vnmq23hNEnbrc_JkVdBVfwk18Hd8KtM9nLo3z3CB0QX0VQbAGs8vLVWzGCQOqZBfoixH0PeKIA/s72-c/ed_headshot.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-6605336228197550771</guid><pubDate>Fri, 24 Oct 2008 13:08:00 +0000</pubDate><atom:updated>2008-10-24T08:29:40.272-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Bob Ehrlich</category><category domain="http://www.blogger.com/atom/ns#">McCain</category><category domain="http://www.blogger.com/atom/ns#">Obama</category><title>Pfizer Hits Ehrlich with $5216 to $8357 in Retiree Health Benefit Costs!</title><atom:summary type="text">For a real life demonstration of how inadequate McCain&#39;s health plan is, even for well-off pharmaceutical company retirees, I offer the following from Bob Ehrlich who wrote in his eNewsletter for DTC Executives (find his entire article over at DTC Perspectives Blog):&quot;I am considered a Pfizer retiree. I worked there for about three days after their takeover of Warner-Lambert in 2000. I am covered </atom:summary><link>http://pharmablogosphere.blogspot.com/2008/10/pfizer-hits-ehrlich-with-5216-to-8357.html</link><author>noreply@blogger.com (PharmaGuy)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-4163301135413680156</guid><pubDate>Thu, 02 Oct 2008 11:59:00 +0000</pubDate><atom:updated>2008-10-02T07:19:22.948-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">McCain</category><category domain="http://www.blogger.com/atom/ns#">Obama</category><category domain="http://www.blogger.com/atom/ns#">Survey</category><title>Check Out McCain&#39;s &quot;Tiki Bar!&quot;</title><atom:summary type="text">Presidential candidate John McCain currently has one of his 7 or so houses up for sale on Realtor.com. I learned about this from Peter Rost&#39;s Blog where you can find the link to the listing of this $12,000,000, 9 Bed, 8 Bath, 14,000 Sq. Ft. house that would cost you $65,619 per month if only you could obtain a mortgage.Scrolling through the 13 photos of this &quot;single-family&quot; dwelling, I found the </atom:summary><link>http://pharmablogosphere.blogspot.com/2008/10/check-out-mccains-tiki-bar.html</link><author>noreply@blogger.com (PharmaGuy)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg1WghxG65fw7uo6NvlclWXCpVIDxKoZGtyfrHI0u-afXaY8zyIfJyGYSZjts0N2x7wOOq9BqPOCI5CVyl8Jk5rexPURqlx8h8PcFggSKe1Vl5lnBK1_fs69v_HVZl0H0Oi5662s3t2M6U/s72-c/McCainTikiBar.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-2310338824452048348</guid><pubDate>Wed, 01 Oct 2008 10:49:00 +0000</pubDate><atom:updated>2008-10-01T06:53:32.558-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Pharma eMarketing Pioneers</category><category domain="http://www.blogger.com/atom/ns#">Recession</category><title>Friends in the Pharma Industry are Losing Their Jobs!</title><atom:summary type="text">We&#39;ve known for a long time that the pharmaceutical industry is in a recession. The results of a poll of readers of Pharma Marketing Blog that I started back in March, 2008 has consistently said so (see &quot;Is the Pharma Industry in a Recession?&quot; and the chart above showing recent results; go to Pharma Marketing Blog to take the poll).We&#39;ve all seen the stories of decreasing pharmaceutical marketing</atom:summary><link>http://pharmablogosphere.blogspot.com/2008/10/friends-in-pharma-industry-are-losing.html</link><author>noreply@blogger.com (PharmaGuy)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgpitf5yN-fsDWn-eezB79MJKnCFFzhEik03hlcJ9LaL972vTTWwdSyxbmP-R5d5_VIEsCsSeW7b-MgmAuCRFVsjDhns-9VPAB4XE0zFXjsL2Z326BzI3bDYiT_JDbXwNTIiwm8qzL516g/s72-c/PharmaRecPollResults.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-7085138998680221521</guid><pubDate>Thu, 11 Sep 2008 14:08:00 +0000</pubDate><atom:updated>2008-09-11T11:10:30.332-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Fabio Gratton</category><category domain="http://www.blogger.com/atom/ns#">IgniteBlog</category><title>IgniteBlog&#39;s Fabio Gratton Used to be Tom Cruise&#39;s Personal Assistant</title><atom:summary type="text">There are only 3 degrees of separation between me and Kevin Bacon! I know and have hung out with Fabio Gratton, who was Tom Cruise&#39;s personal assistant, and Tom Cruise was in the movie A Few Good Men with Kevin Bacon!Fabio, as you may know, founded Ignite Health, a technology-based healthcare communications [got to correct the spelling on your LinkedIn page, Fabio] agency committed to innovating </atom:summary><link>http://pharmablogosphere.blogspot.com/2008/09/igniteblogs-fabio-gratton-used-to-be.html</link><author>noreply@blogger.com (PharmaGuy)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEigRrGixCfOUcF3DwCBJUFEFvFM84w6AVzRo1KK1UxgqCysUr2yDwDyHHa7URpxAT_AhI39ZLGmd8MBV80Q1cs5FEnszmlcUsA06_mpGxaCZXDrr-PNd4N9W5Fo8qhlzy7CGtm2avbxBdc/s72-c/Degrees-of-separation.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-1950506592890033793</guid><pubDate>Wed, 10 Sep 2008 13:50:00 +0000</pubDate><atom:updated>2008-09-10T09:25:38.370-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Ed Silverman</category><category domain="http://www.blogger.com/atom/ns#">Pharmalot</category><category domain="http://www.blogger.com/atom/ns#">WSJ Health Blog</category><title>The Problem with Print Media Blogs</title><atom:summary type="text">I&#39;ve often criticized &quot;blogs&quot; owned by the print media (ie, newspapers) as not being in the same category as &quot;traditional&quot; blogs written by individuals. For one thing, editorial policies that rule these &quot;media blogs&quot; often do not allow readers to &quot;look under the curtain&quot; that news organizations place around the news.Another problem, which I have often noticed with media blogs, is that they tend </atom:summary><link>http://pharmablogosphere.blogspot.com/2008/09/problem-with-print-media-blogs.html</link><author>noreply@blogger.com (PharmaGuy)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgIhN34PHwSo3NKkHGaDS8VWOEqcO8GKs_bRmhEJ_lMDM88p_v9Foq9IVEWbngWdDYJ8ASVLUGGMrYUuSv11n8g7OIrSx377O-eGrIrlT14Kln82w2P8Fg78VB2TZcT2i69F-U2s-zdw5c/s72-c/WSJvPharmalot.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-533078368642299180</guid><pubDate>Mon, 08 Sep 2008 13:02:00 +0000</pubDate><atom:updated>2008-09-08T08:31:28.253-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Fard Johnmar</category><category domain="http://www.blogger.com/atom/ns#">Seal of Approval</category><category domain="http://www.blogger.com/atom/ns#">Survey</category><title>Is a 3rd-Party &quot;Seal of Approval&quot; for Health Blogs Necessary?</title><atom:summary type="text">Fard Johnmar, founder of healthcare marketing communications consultancy Envision Solutions, LLC and author of the blog HealthCareVox, just released results of a new study of the Health Blogosphere. Here are some snippets form the press release:&quot;According to a national survey we commissioned, the U.S. adult health blogging population currently stands at 13.6 million. (We defined health bloggers </atom:summary><link>http://pharmablogosphere.blogspot.com/2008/09/is-3rd-party-seal-of-approval-for.html</link><author>noreply@blogger.com (PharmaGuy)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-7204492983239268306</guid><pubDate>Mon, 18 Aug 2008 11:33:00 +0000</pubDate><atom:updated>2008-08-18T06:57:56.056-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Chris Truelove</category><category domain="http://www.blogger.com/atom/ns#">Journalists</category><title>Pharma Blogger Profile: Chris Truelove - &quot;former inked-stained wretch&quot;</title><atom:summary type="text">It&#39;s the end of summer and practically no-one is at work in the Pharma Blogosphere. But someone who always seems to have a heavy workload is Chris Truelove, a &quot;meta-blogger&quot; over at PharmaBlogReview where she endeavors &quot;to sum up what other bloggers who look at the pharmaceutical and healthcare industries are writing about, combining news and personal views with discussion and a dash of humor.&quot;</atom:summary><link>http://pharmablogosphere.blogspot.com/2008/08/pharma-blogger-profile-chris-truelove.html</link><author>noreply@blogger.com (PharmaGuy)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-8552297278315200476</guid><pubDate>Thu, 31 Jul 2008 18:55:00 +0000</pubDate><atom:updated>2008-07-31T16:10:38.790-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Drug Wonks</category><category domain="http://www.blogger.com/atom/ns#">Pharma Blog Review</category><title>Drug Wonks&#39; Wacko Comments!</title><atom:summary type="text">Chris TrueLove over at Pharma Blog Review notes that she would make some comments about items written in DrugWonks this week, &quot;but hackers and spambots seem to have taken over the comments pages. Go ahead and click on any item in the blog and you’ll see what I mean.&quot;I did and this is what I found:HeroComment:burlington baby depot promo code gray plain tiny myspace layouts medium layered bob mappa</atom:summary><link>http://pharmablogosphere.blogspot.com/2008/07/drug-wonks-wacko-comments.html</link><author>noreply@blogger.com (PharmaGuy)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-3873958206145424535</guid><pubDate>Thu, 31 Jul 2008 12:02:00 +0000</pubDate><atom:updated>2008-07-31T08:08:53.316-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">CNTO411</category><category domain="http://www.blogger.com/atom/ns#">McCain</category><category domain="http://www.blogger.com/atom/ns#">Michael Parks</category><category domain="http://www.blogger.com/atom/ns#">Obama</category><title>Welcome Back CNTO411!</title><atom:summary type="text">Just when I was going to post something about the inactivity over at Centocor&#39;s CNTO411 blog, I see that Michael Parks, Centocor&#39;s Vice President of Corporate Communications and now CNTO411&#39;s only voice, just submitted a post about &quot;GeneRAtions,&quot; a new rheumatoid arthritis awareness program and web site.Parks does not get into what he has been doing since he last made a post over 2 months ago on </atom:summary><link>http://pharmablogosphere.blogspot.com/2008/07/welcome-back-cnto411.html</link><author>noreply@blogger.com (PharmaGuy)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjxyOErltMjlbCDZlKdMCU_Bo6ZdbgBxxJBstaJamkcAq0_rINOnTfNnY1ZpChGxJEw3-vPB_VKa1sk0ssIzXqLAybAdjJfbMkV6k5evsIvh-2dvVU2hLsCWpiT_wL4MjQcb48Lhzmzwpw/s72-c/GeneRAtions-timeline.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-7845674926339828893</guid><pubDate>Tue, 22 Jul 2008 11:42:00 +0000</pubDate><atom:updated>2008-07-22T07:40:01.849-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Gifts to Physicians</category><category domain="http://www.blogger.com/atom/ns#">Jim Edwards’ NRx</category><category domain="http://www.blogger.com/atom/ns#">Pharma Law Blog</category><category domain="http://www.blogger.com/atom/ns#">Pharma Marketing Blog</category><category domain="http://www.blogger.com/atom/ns#">PhRMA</category><title>Like a Bad Penny, Jim Edwards is Back in the Pharma Blogosphere</title><atom:summary type="text">&quot;Like a bad penny, I have opened a new drug news blog, titled &#39;Jim Edwards’ NRx.&#39;&quot;That&#39;s how Jim&#39;s email announcement, which all you bloggers out there have probably received, starts out.You can find Jim&#39;s new blog at http://jimedwardsnrx.wordpress.com/It seems that Jim is simultaneously accepting freelance money from Brandweek--a company he used to work full-time for blogging--and yet claims his</atom:summary><link>http://pharmablogosphere.blogspot.com/2008/07/like-bad-penny-jim-edwards-is-back-in.html</link><author>noreply@blogger.com (PharmaGuy)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi-QDzkWOTtLk6oKicTEtT2r19aAR3XT5ZAcaJQINHLmd-3ElnMM_JQSbwjHegmluzAXKQKbCTrjKd1jGFWpw_Tg9UurynHzvLE_-9AHD_poBt3mRJe0OUyKGALsMRe-C4B3gvufQKqk14/s72-c/bad-penny.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-868356934935513032.post-6061936836430130894</guid><pubDate>Tue, 15 Jul 2008 13:52:00 +0000</pubDate><atom:updated>2008-07-15T09:07:28.140-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Blogger radar</category><category domain="http://www.blogger.com/atom/ns#">PharmaFraud</category><title>Are Employers Cracking Down on Pharma Blogs Written by Employees?</title><atom:summary type="text">First I find that PharmaGiles is deceased (see &quot;Wha Happened to PharmaGiles?&quot;) and now Pharma Fraud access is &quot;by invitation only&quot; and I haven&#39;t been invited!Of course, I&#39;m a conspiracy nut, so right away I sense that these two developments are NOT isolated and may be part of an effort by employers of these bloggers to reign their employees who speak out against the pharmaceutical industry via </atom:summary><link>http://pharmablogosphere.blogspot.com/2008/07/are-employers-cracking-down-on-pharna.html</link><author>noreply@blogger.com (PharmaGuy)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgIU1XM-bEw0UpjfCRAiRXySk_nUb8Sv6orfdm-UG0Y9Zeh-gHbPp-zc_oNO9Rxthpq2d8WE9gIq7q_41B_AAQnY-yiWlfZDO2hbYT7hV8I2fNeDCwSsZEREORw0NVPwtBZB4fqRleEURk/s72-c/PharmaFraud.jpg" height="72" width="72"/><thr:total>0</thr:total></item></channel></rss>